Global Immunotherapy and Immunomodulators Market

1. Summary

The Global Immunotherapy and Immunomodulators Market was valued at $268 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.2% CAGR, to an estimated market size of $398 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global immunotherapy and immunomodulators market includes therapeutic agents designed to modify the immune system's response, encompassing immunosuppressants for autoimmune diseases and organ transplants, as well as immunostimulants such as monoclonal antibodies, checkpoint inhibitors, and cell-based therapies for oncology and infectious diseases.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Immunotherapy and Immunomodulators Market in the period 2025-30:

• The rising global prevalence of autoimmune diseases and chronic inflammatory conditions is driving long-term demand for maintenance immunomodulators.
• Integration of Artificial Intelligence and machine learning is accelerating drug discovery and the development of personalized mRNA-based cancer vaccines.
• A significant shift toward precision medicine is favoring targeted biologics like JAK inhibitors and FcRn blockers over broad-spectrum immunosuppression.
• The rapid expansion of cell-based therapies, particularly CAR T-cell treatments, is gaining regulatory validation for an increasing range of hematologic malignancies.
• The market is seeing increased adoption of combination therapies that integrate immunotherapies with traditional chemotherapy or radiotherapy for enhanced efficacy.
• The entry of biosimilars as major biologic patents expire is improving market accessibility and affordability in developing regions.
• Post-pandemic healthcare strategies have increased R&D investment into immune-based interventions for respiratory and infectious disease complications.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: